> Diabetic macular edema: "New therapeutic solutions for a disease that in Italy affects 210 thousand patients, often in both eyes, and which can lead to blindness"
"The only thing worse than being blind is having sight but no vision."
Helen Keller

 
 
SIFI in the Press: a collection of Press Review's from around the world. For any inquiries regarding these and ongoing press related activities please contact: press@sifigroup.com  ...
 
SIFI, the leading Italian ophthalmic company, has been focused on Eye Care since its foundation in 1935... Download Company Brief Journalists and media operators can write to press@sifigroup.com...
 
SIFI Company Vision Video SIFI Press Conference "Integrated innovations to support the visually impaired" SIFI Diary from ESCRS 2015 with ¡Hasta la Vista SIFI!...

On our Social Channels

From our News Center

SIFI, the Italian leader in ophthalmology, is pleased to announce the acquisition of Dacudoses® and Novoptine®, leading ophthalmic antiseptic brands in France with a total turnover of...
 

 

30 April

SIFI, the Italian leader in the development of therapeutic solutions to treat ophthalmic disorders and global pharmaceutical major, Zydus Cadila, have tied up to market innovative...
Follow Us!